Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Information regarding CEO of Cline Scientific AB

Cline Scientific AB's CEO and board member Patrik Sundh has been informed that he has been served with suspicion of market manipulation and is subject to a preliminary investigation. The suspicions relate to the purchase of B shares in Cline to a value of approximately SEK 62,000, which was carried out during November 2022.The board will not take any measures at the moment, but is awaiting the results of the preliminary investigation and continues to have full confidence in the CEO. Until the preliminary investigation is completed or closed, no further information will be provided in

Investment AB Latour (publ) issues bond loans

Today Investment AB Latour issued two bond loans of in total SEK 1,500 m, within the aggregate nominal amount of the existing MTN program. The first bond loan amounts to SEK 400 m with a tenor of 2.9 years and carries a floating interest rate of three months STIBOR + a margin of 0.87 per cent annually. The second bond loan amounts to SEK 1,100 m with a tenor of 2.9 years and carries a fixed interest rate of 4.078 per cent annually. Handelsbanken and SEB have arranged the issuance. Göteborg, May 5, 2023 INVESTMENT AB LATOUR (PUBL)Johan Hjertonsson, CEO For further information,

Scandinavian ChemoTech Animal Care unit installs its first commercial installation at Evidensia

Vetiqure AB installs the vetIQure™ system at Evidensia Specialist Horse Hospital in Strömsholm with a rental agreement that can generate income of at least EUR 15,000/year.Chief veterinarian Elin Skärlina has, during an evaluation program, treated a number of patients with Tumour-Specific Electroporation, TSE, and has now also received extended training in connection with the treatment of a horse with over 30 melanomas on its body. Melanomas are skin tumours that in horses are also called mold nodules because they are significantly more common on greys (a name for a horse that has

Wulff Group Plc: Manager Transaction – Kari Juutilainen

MANAGERS’ TRANSACTIONS | MAY 5, 2023 AT 4.00 P.M. Wulff Group Plc has received a notification from Kari Juutilainen, Wulff Group Plc’s Board of Directors Chairman, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Name: Kari JuutilainenPosition: Board of Directors MemberIssuer: Wulff Group PlcLEI: 74370016PW2V4W02LX91Notification type: Initial notificationReference

Gambling White Paper: Industry Affiliates React

Last Thursday saw the much-anticipated Gambling White Paper announced in Parliament, which consolidated the findings of a lengthy gambling law review.What was covered? The Department of Culture, Media, and Sport (DCMS) intends to implement a maximum bet per spin for slot machines and will consult on a range between £2 and £15 per spin. Players who lose £1,000 within 24 hours or £2,000 within 90 days will be subject to extensive affordability tests. Meanwhile, operators will be required to conduct "passive" inspections on players whose monthly net losses exceed £125, or £500 annually.

Calliditas Announces Late-Breaking Presentations at the 60th European Renal Association (ERA) Congress 2023

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) announced upcoming data presentations from the NeflgArd Phase 3 Study at the European Renal Association (ERA) Congress 2023.These data presentations will feature data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon (TARPEYO[®] (budesonide) delayed release capsules/Kinpeygo[®]) in patients with IgA nephropathy (IgAN). ERA will be held virtually and in Milan, Italy, June 15-18, 2023.  “We are delighted that these data presentations have been selected for the upcoming ERA Congress 2023

Notice to the Annual General Meeting of Bioretec Ltd

Bioretec Ltd                         Company announcement                5 May 2023 at 3.15 p.m. EESTThe shareholders of Bioretec Ltd are hereby invited to the Annual General Meeting of shareholders to be held on 26th of May 2023 at 11:00 a.m. (Finnish time) at Bioretec premises in the auditorium of Tampark, at the address Yrittäjänkulma 5, FI-33710 Tampere, Finland.   A shareholder may participate in the Annual General Meeting and exercise their rights at the meeting by way of proxy representation. A proxy representative shall present a dated power of attorney or in another reliable

Cinis Fertilizer receives the environmental permit for its first production plant

The Swedish Land and Environment Court in Umeå today announced that an environmental permit has been granted to Cinis Fertilizer AB regarding the production of mineral fertilizer in Köpmanholmen, Örnsköldsvik municipality.“It is very gratifying that we have now received a permit for our operations, and we look forward to claiming the permit. We are thus following our schedule, which means that we will start production of fossil free fertilizer already beginning of next year,” says Jakob Liedberg, CEO Cinis Fertilizer. During the first quarter of 2023, Cinis Fertilizer has completed the

Petter Bäckgren presents Bioservo at Redeye Medtech Event

On May 10 at 13:45, Bioservo's CEO, Petter Bäckgren, will present the latest news from the company at Redeye Medtech Event. The presentation will be broadcast live and can be followed on https://www.redeye.se/events/870864/redeye-medtech-event where the recording and presentations will also be available afterward. Bioservo is a world-leading company in portable, muscle-strengthening systems for the hands that is entering an exciting expansion phase. During the first quarter, the company began delivering a completely new generation of Carbonhand to patients with impaired hand

Report from Extraordinary General Meeting in Intervacc

Intervacc AB (publ) has held its Extraordinary General Meeting (”EGM”) on Friday 5 May 2023, at which a resolution on authorisation for the board of directors to resolve on rights issue of shares was made The EGM authorised the board of directors to, in the period until the next annual general meeting, resolve on a new issue of shares with preferential rights for the company's shareholders. The total number of shares that may be issued based on the authorisation must be within the limits of the share capital according to the articles of association and may not exceed such number of

poLight ASA - Invitation to presentation of Q1 2023 results

poLight ASA (OSE: PLT) will release its first quarter 2023 results on Thursday 11 May 2023 at 7.00 am CEST. The quarterly report and presentation will be made available on the company's website www.polight.com and www.newsweb.no. CEO Øyvind Isaksen and CFO Alf Henning Bekkevik will present the company's results at 09:00 am CEST at Continental, Stortingsgaten 24/26, in Oslo, Norway which is open to the public. The presentation and supporting material will be in English. The presentation can also be followed through live webcast. Please join the Q1 2023 results webcast by clicking https:

Asarina Pharma’s positive Phase IIa Tourette Syndrome results to be presented at TicCon, the Virtual National Conference of the Tourette Association of America

(Stockholm, May 5, 2023) On May 19, 2023 Asarina Pharma’s positive results from its Phase IIa Study in Tourette Syndrome will be presented at TicCon, the Virtual National Conference of the Tourette Association of America, by Assoc. Prof. Marco Bortolato (Dept Pharmacology & Toxicology, University of Utah). The results were an important target validation of Assoc Prof. Bortolato’s thesis that the powerful neurosteroid Allopregnanolone (ALLO) is a key target in the pathogenesis of Tourette, and that Asarina’s endogenous compound Sepranolone modulates ALLO´s effects.The Phase IIa results

Safello enables instant payments

Stockholm, 5 May 2023 | Safello, the leading crypto exchange in the Nordics, announces that instant payments are now available as a payment method for transactions.  Safello’s customers can now safely buy digital assets using an instant payment method. The option to use instant payments is provided by a third party payment service provider. Customers choosing instant payment enters into an agreement with the payment service provider that executes payments via open banking API’s. The payment service provider is a registered Swedish entity, licensed as a payment institution under the SFSA

Implantica presents the first quarter 2023 on May 12 at 15:00 CET

Implantica AG (publ) invites investors to a presentation of the first quarter 2023 at 15:00 CET on May 12. The interim report for the first quarter will be published at 8:00 a.m. CET on the same day.The presentation will be in English via an audiocast with teleconference: Conference call dial-in: · Sweden: +46 8 505 163 86 · United Kingdom: +44 20 319 84884 · United States: +1-412-317-6300 Pin code: 9354290# Webcast: · https://ir.financialhearings.com/implantica-q1-2023  Speakers: · CEO Peter Forsell ·

Everysport Group divests shares in subsidiary

Everysport Group AB (publ) today announces an agreement with Grundbulten 118007 AB (under name change to DRW Padeltour AB) concerning the divestment of 80 percent of the shares in the Group’s subsidiary Grundbulten 117847 AB (under name change to Every Padel Hedenstorp AB). The transaction relates to the Group's padel facility in Hedenstorp, Jönköping and was completed on May 1, 2023."We continue to implement strategic decisions that create the conditions for long-term growth in the core business, which started the year strongly with increased net sales, positive EBIT and profit

Metso Corporation: Managers' transactions – Brian Beamish

Metso Corporation’s stock exchange release on May 5, 2023, at 2:00 p.m. EESTMetso Corporation has received the following disclosure under EU Market Abuse Regulation No 596/2014, regarding managers' or their closely associated persons' transactions with Metso's shares. Person subject to the notification requirementName: Beamish, BrianPosition: Member of the Board Initial NotificationReference number: 549300R0VN9C371W0E07_20230504161023_232 IssuerName: Metso CorporationLEI:

Metso Corporation: Managers' transactions – Emanuela Speranza

Metso Corporation’s stock exchange release on May 5, 2023, at 2:00 p.m. EESTMetso Corporation has received the following disclosure under EU Market Abuse Regulation No 596/2014, regarding managers' or their closely associated persons' transactions with Metso's shares. Person subject to the notification requirementName: Speranza, EmanuelaPosition: Member of the Board Initial NotificationReference number: 549300R0VN9C371W0E07_20230504161023_238 IssuerName: Metso CorporationLEI:

M.O.B.A. Network acquires Wargraphs S.A.S, and explores the possibility to issue senior secured bonds

M.O.B.A. Network AB (publ) (the “Company”) has entered into a conditional agreement to acquire all shares in the French entity Wargraphs S.A.S (“the “Target”) (the “Acquisition”), a leading gaming services provider and in-game application developer for League of Legends, Teamfight Tactics and Legends of Runeterra. The consideration for the Acquisition amounts to a maximum of EUR 50.0 million, of which EUR 25.0 million is payable upfront (the “Initial Consideration”) plus an additional consideration of up to a maximum of EUR 25.0 million based on the Target achieved EBITDA for 12 and 24

Metso Corporation: Managers' transactions – Arja Talma

Metso Corporation’s stock exchange release on May 5, 2023, at 2:00 p.m. EESTMetso Corporation has received the following disclosure under EU Market Abuse Regulation No 596/2014, regarding managers' or their closely associated persons' transactions with Metso's shares. Person subject to the notification requirementName: Talma, ArjaPosition: Member of the Board Initial NotificationReference number: 549300R0VN9C371W0E07_20230504161023_240 IssuerName: Metso CorporationLEI:

Metso Corporation: Managers' transactions – Klaus Cawén

Metso Corporation’s stock exchange release on May 5, 2023, at 2:00 p.m. EESTMetso Corporation has received the following disclosure under EU Market Abuse Regulation No 596/2014, regarding managers' or their closely associated persons' transactions with Metso's shares. Person subject to the notification requirementName: Cawén, KlausPosition: Member of the Board Initial NotificationReference number: 549300R0VN9C371W0E07_20230504161023_233 IssuerName: Metso CorporationLEI:

Metso Corporation: Managers' transactions – Terhi Koipijärvi

Metso Corporation’s stock exchange release on May 5, 2023, at 2:00 p.m. EESTMetso Corporation has received the following disclosure under EU Market Abuse Regulation No 596/2014, regarding managers' or their closely associated persons' transactions with Metso's shares. Person subject to the notification requirementName: Koipijärvi, TerhiPosition: Member of the Board Initial NotificationReference number: 549300R0VN9C371W0E07_20230504161023_234 IssuerName: Metso CorporationLEI:

There are no items matching the current filter
There are no more items matching the current filter
Back to top